By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tocagen Inc. 

3030 Bunker Hill Street
Suite 230
San Diego  California  92109  U.S.A.
Phone: 858-412-8400 Fax: 858-412-8499


SEARCH JOBS








Company News
Tocagen Inc. To Present At The Immunotherapy World Forum 2016 1/26/2016 7:59:33 AM
First Patient Enrolled In Toca 5, Tocagen Inc.'s Phase II/III Clinical Trial In Patients With Recurrent Glioblastoma Or Anaplastic Astrocytoma 12/3/2015 6:28:32 AM
Tocagen Inc. Presents Interim Data From Studies Evaluating Toca 511 & Toca FC At The Annual Meeting Of The Society For Neuro-Oncology (SNO) 11/23/2015 6:34:33 AM
Tocagen Inc. To Present Interim Results From Studies Evaluating Toca 511 & Toca FC At The Annual Meeting Of The Society For Neuro-Oncology (SNO) 11/18/2015 6:36:15 AM
Lori Kunkel, M.D., Joins Tocagen Inc.'s Board Of Directors 9/10/2015 7:20:02 AM
Tocagen Inc. To Present At BioCentury's NewsMakers In The Biotech Industry Conference 9/3/2015 7:35:24 AM
FDA Grants Orphan Drug Designation For Tocagen Inc.'s Toca 511 & Toca FC, An Investigational Immuno-Oncology Treatment For Glioblastoma 8/25/2015 6:21:06 AM
FDA Grants Fast Track Designation To Tocagen Inc.'s Toca 511 & Toca FC For Treatment Of Recurrent High Grade Glioma 7/9/2015 9:58:19 AM
Tocagen Inc. Appoints Asha Das, M.D., As Vice President Of Clinical Development 6/17/2015 7:58:07 AM
Tocagen Inc. Appoints David R. Parkinson, M.D., To The Board Of Directors 5/5/2015 6:30:36 AM
123
//-->